Amneal Pharmaceuticals, Inc. (AMRX) Sharpe Ratio: 1.46

AMRX's Sharpe Ratio of 1.46 indicates that for each unit of volatility, it generates 1.46 units of excess return above the risk-free rate. The ratio is calculated using historical daily returns over the past 12 months (as of Apr 1, 2026).

Sharpe uses total volatility (standard deviation) which includes both upside and downside price movements, making it useful for comparing risk-adjusted returns across different assets.

AMRX Sharpe Ratio Rank

Exceptional

AMRX ranks above 84.1% of all investments in our database based on Sharpe Ratio over the past 12 months, demonstrating exceptional risk-adjusted returns. Securities are ranked from 0 (worst) to 100 (best).

What moves the rank

Strong returns with low total volatility → Higher rank
High volatility (both upside and downside) → Lower rank
Consistent returns → Higher rank than volatile returns of same magnitude
Sharp drawdowns increase volatility → Lower rank

What you can do with this information

Suitable as a core holding given strong risk-adjusted returns
Monitor rank changes to detect deteriorating return-to-volatility profile
Exceptional Sharpe ratio supports larger position sizes
Compare with category peers to assess whether strength is investment-specific or category-wide

AMRX Sharpe Ratio Market Positioning

The chart shows AMRX's Sharpe Ratio relative to all stocks on our platform, with color zones indicating percentile rankings. Higher ratios indicate better risk-adjusted returns.

Red zone (bottom 25%): -0.34 or lower
Yellow zone (middle 50%): -0.34 to 1.06
Green zone (top 25%): 1.06 or higher
Top 1%: 4.65+
Median: 0.25 — half of all investments score higher

How it compares to other similar stocks

The table compares Amneal Pharmaceuticals, Inc.'s Sharpe Ratio with other stocks in the Drug Manufacturers - Specialty & Generic industry across multiple time periods, showing how AMRX's risk-adjusted performance compares to industry peers.

Data shows 1-, 5-, and 10-year periods, plus each stock's all-time average, as of Apr 1, 2026.

Symbol	Name	1Y Sharpe Ratio
RGC	Regencell Bioscience Holdings Limited	7.76
INDV	Indivior PLC Ordinary Shares	5.03
BIOA	BioAge Labs, Inc	4.64
PAHC	Phibro Animal Health Corporation	3.09
SDZNY	Sandoz Group AG	2.87
ELAN	Elanco Animal Health Incorporated	2.54
TEVA	Teva Pharmaceutical Industries Limited	2.29
SGIOY	Shionogi & Co Ltd ADR	1.86
IPSEY	Ipsen SA ADR	1.81
VTRS	Viatris Inc.	1.81
AMRX	Amneal Pharmaceuticals, Inc.	1.46

Benchmark Against

Benchmark

S&P 500 Index

Lookback Period

How to choose period

Historical Sharpe Ratio

The chart shows AMRX's rolling Sharpe ratio over time compared to your chosen benchmark. Rising trends indicate improving returns relative to total volatility, while declining trends may signal deteriorating risk-adjusted performance or increased volatility. Use multiple timeframes to distinguish short-term fluctuations from long-term patterns.

Identify market cycles by observing when AMRX consistently outperforms (line above benchmark), underperforms (below benchmark), or aligns with the benchmark.

Loading graphics...

Explore AMRX risk-adjusted metrics in detail

Dive deeper into individual metrics with historical trends, benchmark comparisons, and performance across different time periods.

AMRX Sortino Ratio